KEY FINDINGS The Europe electronic skin patches market is registered to project a CAGR of 16.41%, during the forecast years of 2021 to 2028. The region’s key market growth drivers are, the surging number of research and development activities, the rising healthcare expenditure, and the increasing geriatric population.
MARKET INSIGHTS The Europe electronic skin patches market growth is assessed by evaluating France, Poland, Germany, the United Kingdom, Russia, Belgium, Italy, and the rest of Europe.On the other hand, healthcare is the key division, in terms of Germany’s economy.
The country’s medical device market is relatively sophisticated, with the demand for innovative devices observing a growing trend.Besides, the growing incidence of chronic and lifestyle-related diseases, the surging aging population, and the need for monitoring and diagnosis, plays an important role in fuelling the country’s demand for electronic skin patches.
For example, according to a 2019 article, Germany’s mortality rate due to heart diseases increased over recent years, following a stable decline in the last two decades.
On the other hand, Italy’s life expectancy rate is high.However, this factor increases the burden of chronic conditions in the country.
The incidence of chronic as well as lifestyle-related diseases observes rapid growth in Italy, resulting in the increased demand for skin patches, for patient monitoring.For example, according to the Organisation for Economic Co-operation and Development (OECD), over 66% of all deaths in Italy, were associated with cardiovascular conditions and cancer.
Hence, these factors are anticipated to propel the market growth, over the forecast period.
COMPETITIVE INSIGHTS Prominent companies operating in the market include, Koninklijke Philips NV, Medtronic PLC, Nemaura Medical Inc, etc.
Our report offerings include: • Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
Increasing demand from drug delivery and catheters and cannulas to drive the overall growth of the medical tubing market The US medical tubing market size is expected to grow from USD 2.6 billion in 2020 to USD 2.9 billion by 2021, at a CAGR of 13.2% during the forecast period. The medical tubing industry is driven by various...
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
The global transradial access market is expected to reach US$ 2,961.79 Mn in 2027 from US$ 1,574.97 Mn in 2018. The market is estimated to grow with a CAGR of 7.7% from 2019-2027. The market for transradial access is expected to grow, owing to factors such as rising inclination for interventional procedures using radial artery access, increasing...
The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions...
The global drug delivery systems market is expected to reach US$ 2,302.2 Bn in 2027 from US$ 1,243.1 Bn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027. The market is driven by the factors such as, rising incidence of chronic diseases, growing demand for non-invasive drug delivery devices, increasing R&D expenditures...
Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018. How...
Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (U.S., U.K., Canada, Germany), And Segment Forecasts, 2018 - 2025 The global acute repetitive seizures market size is expected to reach USD 3.19 billion by 2025, according to a new report by Grand...
620 pages •
By Roots Analysis Private Ltd.
• Oct 2018
INTRODUCTION Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to be associated with negative health outcomes, inflated medical expenses, loss in productivity and, in certain cases, proves fatal as well. It has been estimated that, of the ~4 billion annual prescriptions...
The transradial access devices market is estimated to grow at a CAGR of 7.5% during the forecast period The global transradial access devices market is expected to grow at a CAGR of 7.5% to reach to USD 2.18 billion by 2022 from an estimated USD 1.52 billion in 2017. The driving factors of this market are rising prevalence...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.